Smoldering Systemic Mastocytosis — Trials

Smoldering Systemic Mastocytosis — Trials · CancerIndex

Clinical trials

Registered studies

3 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05186753	(Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis	active not recruiting	Phase 2	237	Cogent Biosciences, Inc.INDUSTRY	15	May 22, 2026	clinicaltrials

Data updated 22 days agoSource updated May 22, 2026source: clinicaltrials